ÂÜÀòÂÒÂ×

Ann-Lise Mikolajczak is a seasoned professional in global health and access policy, currently serving as a secondee for Global Access Policy at Roche since June 2024 and holding the position of Associate Director for Global Health and Access at IFPMA since June 2019. With extensive experience in advocacy, public affairs, and strategic policy development, Ann-Lise has positioned the global innovative pharmaceutical industry as a strategic partner in initiatives related to non-communicable diseases, rare diseases, and climate change. Previous roles include contributions at Sanofi and MSD, where Ann-Lise focused on public health promotion, market access, and pricing strategies. Ann-Lise's educational background includes diverse pharmacy and public health degrees from institutions such as Université Paul Sabatier Toulouse III and the London School of Economics.